People: Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

95.41EUR
15 Aug 2014
Price Change (% chg)

€-2.28 (-2.33%)
Prev Close
€97.69
Open
€97.78
Day's High
€98.45
Day's Low
€95.03
Volume
2,510,992
Avg. Vol
1,720,322
52-wk High
€112.95
52-wk Low
€83.72

Search Stocks

Malik, Kemal 

Brief Biography

Dr. Kemal Malik is Member of the Management Board responsible for Innovation and the North America region at Bayer AG effective February 1, 2014. Dr. Malik spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions in medical affairs and clinical development at Bristol-Myers Squibb in the United Kingdom. Dr. Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development. He was a member of the Executive Committee of Bayer HealthCare AG from July 1, 2007 until his appointment to the Board of Management of Bayer AG. He was also Head of Global Development and Chief Medical Officer in the Pharmaceuticals Division. He studied medicine at Charing Cross and Westminster Medical School (University of London), graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Werner Wenning

368,000

Marijn Dekkers

4,832,000

Hermann Strenger

--

Thomas de Win

247,000

Werner Baumann

2,945,000

Michael Koenig

1,642,000
As Of 30 Dec 2013
Search Stocks